Part B Pharmacy Policies
Navigate directly to a letter:
-
A
- ANIFRO~2.PDF
- Abatacept (Orencia®) for Injection for Intravenous Use
- Agalsidase beta (Fabrazyme®)
- Alemtuzumab (Lemtrada®)
- Alglucosidase alfa (e.g., Lumizyme®)
- Alpha 1-Antitrypsin Therapy (e.g., Prolastin-C, Aralast NP, Glassia, Zemaira)
- Anifrolumab-fnia (Saphnelo™)
- Anifrolumab-fnia_(Saphnelo)_2.pdf
-
B
- Belimumab (Benlysta®) for Intravenous Use
- Botulinum_Toxin_Agents.pdf
- Botulinum_Toxin_Agents_2.pdf
- Burosumab-twza (Crysvita®)
-
C
- Canakinumab (Ilaris®)
- Cerliponase alfa (Brineura®)
- Coagulation Factors
- Collagenase clostridium histolyticum (Xiaflex®), collagenase clostridium histolyticum-aaes (Qwo™)
- Crizanlizumab-tmca (Adakveo®)
-
D
- Denosumab (Prolia®, Xgeva®), Romosozumab-aqqg (Evenity®)
- Dofetilide (Tikosyn®) Use in the Inpatient Setting
-
E
Back to top ↑ -
L
Back to top ↑